ASN Podcast

Tod Ibrahim and David White discuss priorities for early intervention, transplant, innovation, and equity in 2022.

Tod Ibrahim and Dr. Girish Nadkarni discuss augmented intelligence and its future in health care and nephrology.

Tod Ibrahim and David White discuss the latest news from Capitol Hill affecting kidney medicine and health care in general.

Dr. Michelle Josephson, Dr. Mukta Baweja, and Dr. Laura Maursetter discuss ASN's "United 4 Kidney Health" campaign, particularly the priorities to intervene earlier and reduce disparities in kidney care.

Tod Ibrahim, Dr. Kirk Campbell, and Dr. Catherine Godson talk about the legacy of the late Dr. Barbara Murphy, including her professional work and personal nature.

ASN President Dr. Susan Quaggin talks to Dr. Katherine Tuttle about the latest developments in the field of diabetic kidney disease.

Tod Ibrahim talks to Dr. Mary Dittrich, Chief Medical Officer and Executive Vice President of US Renal Care, about her trailblazing work in using monoclonal antibodies to treat COVID-19.

Elections, the debt ceiling, vaccines -- Tod Ibrahim and David White discuss how recent political and regulatory issues affect the health care community.

Tod Ibrahim talks to Dr. Sam Kant and Dr. Dana Larsen, who give advice to first-year nephrology fellows.

Tod Ibrahim and David White review several proposed federal regulations and how they affect the field of nephrology.

Tod Ibrahim and David White discuss home dialysis, challenges to the Affordable Care Act, and other policy issues.

Tod Ibrahim and David White review policy issues to be tackled this summer, including vaccines, telehealth, and kidney care payment models.

Tod Ibrahim and David White discuss federal funding for kidney research, visas for international medical graduates, and the Equality Act.

Tod Ibrahim and Dr. Ray Bignall discuss issues of race in nephrology and how ASN's new Health Care Justice Committee will address them.

Tod Ibrahim and David White discuss the Biden administration's first 100 days, specifically the vaccine situation and regulatory issues related to kidney transplantation.

Tod Ibrahim and David White discuss the federal budget process and what that means for kidney and health care policy in the US.

Tod Ibrahim and David White discuss a new White House initiative to get kidney patients vaccinated in dialysis centers. They also discuss what's happening in the world of transplant policy.

Tod Ibrahim talks to Dr. Suzanne Watnick and Elizabeth McNamara of Northwest Kidney Centers about what they've learned since COVID-19 first hit the US last year.

Tod Ibrahim and David White update listeners on the Affordable Care Act, transplant policy, and the mandatory and voluntary payment models for nephrologists.

Tod Ibrahim and David White discuss how the composition of the Senate might affect policy discussions, as well as the Biden administration's executive orders on addressing disparities in health care and society at large.

Tod Ibrahim and David White talk about what could happen for kidney care and health care in 2021.

Tod Ibrahim and David White talk about the end-of-year stimulus package from Congress and the recent approval of full immunosuppressive drug coverage for kidney transplant recipients.

Tod Ibrahim and David White discuss what the health care team will look like in a Biden-Harris administration.

Tod Ibrahim and David White review what the federal government is doing to promote awareness of kidney diseases, improve treatment options, and fund research, discovery, and innovation.

Tod Ibrahim and David White discuss the implications of the presidential election and what the new government's agenda could look like.